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Harm reduction in the Heartland: public
knowledge and beliefs about naloxone
in Nebraska, USA
Allison Schlosser1* , Patrick Habecker2 and Rick Bevins2,3

Abstract
Background: Opioid-related overdose deaths have been increasing in the United States (U.S.) in the last twenty
years, creating a public health challenge. Take-home naloxone is an effective strategy for preventing opioid-related
overdose death, but its widespread use is particularly challenging in smaller cities, towns, and rural areas where it may
be stigmatized and/or poorly understood.
Methods: We analyzed data on knowledge and beliefs about drug use and naloxone among the general public
in Nebraska, a largely rural state in the Great Plains region of the U.S., drawing on the 2020 Nebraska Annual Social
Indicators Survey.
Results: Respondents reported negative beliefs about people who use drugs (PWUD) and little knowledge of naloxone. Over half reported that members of their community view PWUD as blameworthy, untrustworthy, and dangerous. Approximately 31% reported being unaware of naloxone. Only 15% reported knowing where to obtain naloxone
and less than a quarter reported knowing how to use it. Knowing where to obtain naloxone is associated with access
to opioids and knowing someone who has recently overdosed, but having ever used opioids or being close to someone who uses opioids is not associated with naloxone knowledge. Finally, almost a quarter of respondents endorsed
the belief that people who use opioids will use more if they have access to naloxone.
Conclusion: Our findings highlight stigmatizing beliefs about PWUD and underscore the need for further education
on naloxone as an effective strategy to reduce opioid-related overdose death. We highlight the implications of these
findings for public education efforts tailored to non-urban communities.
Keywords: Harm reduction, Naloxone, Narcan®, Opioid use, Rural health, United States
Introduction
In the last twenty years, the United States (U.S.) has
struggled to respond to what is now commonly referred
to as an “overdose crisis.” In 2019, over 70,000 people died
of a drug overdose in the U.S.—more than four times the
1999 total—and over two-thirds of these deaths involved
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an opioid [1]. Provisional data suggest an acceleration of
overdose deaths during the novel coronavirus (COVID19) pandemic. In the 12 months ending in April 2021,
over 100,000 drug overdose deaths occurred; an increase
of nearly 30% compared to the prior year [2].
Opioid-related overdose deaths can be prevented with
the timely administration of naloxone, an opioid antagonist that quickly reverses opioid‐induced respiratory
depression [3]. Take-home naloxone (THN)—the provision of naloxone to people who use opioids and others
likely to witness an overdose and training on its administration—is a harm reduction intervention that aims to
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decrease the negative consequences of drug use without
requiring its elimination [4] . In 2014, the World Health
Organization recommended THN as a tool for the community management of opioid overdose [5]. The ongoing
rise of opioid-related overdose deaths, however, highlights the insufficient adoption of THN as well as the
need for greater investment in public awareness and support of this strategy to realize its full potential [5].
Notably, social stigma associated with drug use and
“addiction” limits the accessibility of naloxone [6].
Despite a worsening overdose crisis and evidence of the
public health benefits of naloxone, THN often faces significant political resistance, particularly in smaller cities,
towns, and rural areas [7]. On this point, Ezell et al. [8]
argue that stigma against people who use opioids and
harm reduction interventions may be particularly problematic in rural areas because of decreased anonymity
along with limited access and/or resistance to “neutralizing” information on these topics. This possibility underscores the need for more research on attitudes regarding
opioid use and THN in rural areas that are increasingly
affected by the overdose crisis [9].
Nebraska, a largely rural state in the Central Great
Plains region of the U.S., has not been spared from the
overdose crisis. In 2018, nearly 35% of the 138 overdose
deaths in the state involved an opioid [10]. From October 2019 to October 2020, there was a 39.7% increase in
all drug overdose deaths in the state, surpassing the 30%
increase seen in the U.S. overall [11]. In 2015, a Nebraska
law authorized prescribers and dispensers to distribute
naloxone to family members, friends, and others who
may be positioned to assist someone experiencing an
opioid-related overdose and provided administrative,
civil, and criminal immunity for individuals administering naloxone [12].
Despite these policy changes, THN has not been widely
disseminated in the state [13]. To better understand this
lack of adoption, this paper explores knowledge and
beliefs about opioid use and naloxone among the general public in the state drawing on data from the 2020
Nebraska Annual Social Indicators Survey (NASIS).

Methods
We use data from the NASIS, a paper survey mailed to
an address-based sample of 8,000 adult Nebraskans (19
is the age of majority in Nebraska) in late July through
November 2020. The 2020 NASIS sample was stratified by the six Behavioral Health Regions of the state
plus Omaha and Lincoln, the two largest cities in the
state. One thousand addresses were selected at random
in each of the eight mutually exclusive strata. A map of
the regions and a list of the ZIP codes used to define
the borders of Omaha and Lincoln are available in the
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2020 NASIS methodology report [14]. The University of
Nebraska Lincoln Institutional Review Board approved
this research (#20160816236FB).
The overall response rate for the 2020 NASIS was
27.7% (AAPOR RR2) with 11% of the mailings postmaster returned because of vacancies or other address ineligible codes. Due to the stratified sample design, weights
are used to account for chance of selection by strata,
within household probability of selection, nonresponse,
and post-stratification for region, age, and gender. All
analyses in this paper use weights in Stata 15 with the
svy command. After removing cases with missing data,
we have a sample of 1712. The average age of the sample
was 49, ranging from 19 to 99, half of the sample were
women, and 90% said they were White and not Hispanic.
Fifty percent of the sample had a four-year degree or
higher, 35% had some college or a technical degree, and
15% had a high school degree or less. Additionally, 53.4%
percent of the sample reported household income greater
than $75,000 in the past year, 19.8% reported $50,000$75,000, and 26.8% reported less than $50,000.

Results
We present results related to knowledge and beliefs
about drug problems and access to opioids, people who
use drugs (PWUD) and substance use disorder (SUD),
and drug overdose and naloxone (see Table 1: Key survey questions and outcomes). We then present a multinomial logistic regression model predicting knowledge
about where to get naloxone if a respondent needed it.
We use the phrase “substance use disorder” in this report
because this language was used in some NASIS survey
questions. However, we acknowledge that this language
may inaccurately communicate that the source of the disorder is in the individual and not the social and economic
environment.
Drug concerns and opioid access

Respondents expressed a high level of concern about
drug use in the country and in their communities. Over
92% reported that drug use is a moderately big or very big
problem in the U.S. overall. More than 61% also reported
this level of concern about drug use in their local communities. Additionally, respondents reported the ability
to access opioids in ways other than through a prescription: 8.7% reported the ability to obtain heroin and 12.1%
reported the ability to obtain opioids other than heroin
without a prescription. Furthermore, 2% reported knowing someone close to them that currently uses heroin and
about 6% reported knowing someone close to them that
currently uses opioids other than heroin. Only 0.7% of
respondents reported ever using heroin in their lifetime,
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Table 1 Key survey questions and outcomes (n = 1712)
Estimated
percent

Table 1 (continued)
Estimated
percent

Estimate 95%
confidence
intervals

How much of a problem do you think drug addiction is in the country
today?

Estimate 95%
confidence
intervals

Strongly disagree

1.8

1.0

2.9

Disagree

7.9

6.3

9.7

Not at all a problem

0.5

0.2

1.5

Neither disagree or agree

26.6

23.9

29.5

A small problem

7.0

5.5

8.8

Agree

49.3

46.1

52.6

Strongly agree

14.4

12.3

16.9

A moderately big problem

41.5

38.3

44.8

A very big problem

51.0

47.8

54.3

How much of a problem do you think drug addiction is in your local
community today?
Not at all a problem

3.0

2.1

How much do you disagree or agree that you are able to recognize a
person overdosing?
Strongly disagree

4.4

Disagree

4.9

3.7

6.6

20.0

17.5

22.7

A small problem

35.7

32.7

38.9

Neither disagree or agree

38.4

35.3

41.6

A moderately big problem

43.2

40.0

46.5

Agree

28.5

25.7

31.5

A very big problem

18.1

15.7

20.8

8.2

6.5

10.3

Have you ever used the following substances in ways other than
through a prescription in your lifetime?

Strongly agree

Do you know anyone who has experienced a drug overdose in the past
year?

Heroin

0.7

0.3

1.5

Yes

7.4

5.8

9.4

Opioids other than heroin

4.8

3.5

6.6

No

92.6

90.6

94.2

Combined

4.8

3.5

6.6

Could you get the following substances in ways other than through a
prescription if you wanted to?
8.7

7.1

10.8

Opioids other than heroin

Heroin

12.1

10.1

14.5

Combined

12.1

10.1

14.5

Do you know anyone close to you that currently uses any of these
substances in ways that are not prescribed?
Heroin

2.0

1.2

3.3

Opioids other than heroin

6.1

4.6

8.1

Combined

6.4

4.8

8.4

How much do you disagree or agree that a substance use disorder can
be stopped at any time if the person truly wants to?
Strongly disagree

22.3

19.7

25.0

Disagree

33.8

30.8

37.0

Neither disagree or agree

19.2

16.9

21.9

Agree

19.6

17.1

22.4

5.1

3.8

6.8

Strongly agree

Most people in my community believe that a person who uses cocaine,
methamphetamine, opioids, or heroin cannot be trusted
Strongly disagree

1.0

0.5

1.7

Disagree

3.2

2.3

4.4

Neither disagree or agree

16.4

14.1

18.9

Agree

54.7

51.4

57.9

Strongly agree

24.7

22.0

27.6

Most people in my community believe that a person who uses cocaine,
methamphetamine, opioids, or heroin is dangerous
Strongly disagree

0.9

0.5

1.6

Disagree

3.7

2.8

5.0

Neither disagree or agree

21.2

18.7

24.0

Agree

53.8

50.5

57.0

Strongly agree

20.4

17.9

23.1

Most people in my community believe that a person who uses cocaine,
methamphetamine, opioids, or heroin is to blame for their own problems

Do you know where to get Narcan® (naloxone) if you needed it?
Yes

15.0

12.9

17.5

No

53.7

50.4

56.6

I don’t know what this is

31.3

28.3

34.4

and 4.8% reported using opioids other than heroin in
ways other than prescribed in their lifetime.
Beliefs about SUD and PWUD

In addition to significant concern about drug use,
respondents expressed potentially stigmatizing beliefs
about SUD and PWUD. A quarter of the sample
expressed the belief that having a SUD is a choice, agreeing or strongly agreeing that SUD can be stopped at any
time if the person truly wants to quit (about 20% were
neutral; 56% disagreed or strongly disagreed). Respondents also expressed negative attitudes about people who
use cocaine, methamphetamines, and heroin or other
opioids in their communities. The majority of respondents agreed or strongly agreed that most people in their
community view these individuals as untrustworthy
(79%), dangerous (74%), and deserving of blame (64%).
Overdose and naloxone

Despite concern about the severity of drug problems in
their local communities and knowledge of people who
are currently using opioids, a quarter of respondents
reported that they would be unable to recognize when
a person is overdosing—almost 40% were neutral. Only
15% reported that they know where to get naloxone (also
referred to as Narcan® on the survey) if they needed
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it. Further, less than a quarter (22%) reported that they
know how to use naloxone. Moreover, approximately 31%
reported being unaware of naloxone altogether. Finally,
while just under a quarter of respondents reported the
belief that people who use heroin or other opioids will
use more of these drugs if they have access to naloxone,
over half (58%) responded neutrally.
Naloxone awareness: associations

To better understand patterns of naloxone knowledge, we
used multinomial logistic regression to test associations
between knowledge and several individual, geographic,
and opioid-related factors (see Table 2: Multinomial
regression model predicting knowledge of where to get
naloxone). The model tests differences between people
who know how to obtain naloxone (responded "Yes") and
those who do not know what naloxone is, and the differences between those who do not know how to obtain

naloxone (responded “No”) and those who do not know
what naloxone is.
We found that knowledge of naloxone is associated
with age and gender. Older participants have lower
odds of knowing how to get naloxone (p = 0.044) compared to not knowing what it is. Compared to men,
women have 1.9 times greater odds of knowing where
to get naloxone compared to not knowing what it is
(p = 0.003). Additionally, knowing where to obtain
naloxone is associated with access to opioids and knowing someone who has recently overdosed. Those who
reported having access to opioids have 3.6 times higher
odds of knowing where to get naloxone than reporting
that they do not know what it is (p < 0.001). Respondents who know somebody who overdosed in the past
year also have 2.9 times higher odds of knowing where
to get naloxone than saying they do not know what it is
(p = 0.007). However, having ever used opioids or being
close to someone who uses opioids is not associated
with naloxone knowledge. Nor were there differences

Table 2 Multinomial regression model predicting knowledge of where to get naloxone (n = 1712)
Measure

Age

Model 1: "Yes" compared to "I don’t know
what this [Narcan®] is"

Model 2: "No" compared to "I don’t
know what this [Narcan®] is"

exp(b)

p value

95% CI

exp(b)

p value

95% CI

0.986

0.044

0.974

1.000

1.007

0.121

0.998

1.016

Political party
Democrat

(reference)

Republican

0.657

0.117

0.388

1.111

(reference)
0.654

0.033

0.442

0.967

Independent

0.674

0.192

0.372

1.220

0.876

0.551

0.566

1.354

Other party

0.869

0.799

0.294

2.569

0.796

0.571

0.362

1.751

Gender
Male

(reference)

Female

1.904

0.003

1.247

2.907

(reference)
1.166

0.322

0.860

1.581

White and not Hispanic or Latino

1.6959

0.211

0.750

3.674

1.571

0.079

0.949

2.603

Not White

(reference)

Self-described race
(reference)

Nebraska behavioral health regions with separate Omaha and Lincoln
Panhandle

0.498

0.110

0.212

1.171

0.854

0.569

0.496

1.471

Southwest

0.994

0.988

0.434

2.272

0.938

0.952

0.559

1.729

South central

0.964

0.930

0.432

2.155

0.927

0.780

0.545

1.578

North

1.325

0.500

0.585

3.004

0.770

0.349

0.445

1.332

Southeast without Lincoln

1.222

0.599

0.578

2.580

0.797

0.424

0.456

1.391

Midlands without Omaha

0.722

0.394

0.341

1.528

0.807

0.395

0.493

1.323

Lincoln

1.000

0.999

0.493

2.025

0.912

0.722

0.548

1.516

Omaha

(reference)

(reference)

Ever used opioids (Heroin/others)

0.949

0.935

0.270

3.338

1.631

0.299

0.647

4.111

Close to someone who uses opioids (Heroin/others)

1.045

0.922

0.432

2.526

1.021

0.959

0.465

2.243

Has access to opioids (Heroin/others)

3.608

0.000

1.890

6.886

1.328

0.312

0.767

2.299

Knows anyone who overdosed in past year

2.887

0.007

1.335

6.244

1.437

0.312

0.711

2.904

Intercept

0.419

0.147

0.129

1.360

1.028

0.946

0.459

2.304
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by identifying as White or not, the region of Nebraska
where the respondent lives, or if they live on a farm,
open country, or in a town or city.

Discussion
Our findings highlight the need for further education on
PWUD, SUD, and naloxone as an effective harm reduction strategy to reduce opioid-related overdose death in
Nebraska. We estimate that 6% of adults in the state know
someone close to them who uses opioids without a prescription. This group represents a population for which
knowledge of and access to naloxone can directly prevent overdose deaths. In regression testing, being close to
someone who used opioids is not associated with naloxone knowledge, nor is a personal history of opioid misuse.
However, having access to opioids and knowing somebody
who overdosed in the past year is associated with higher
odds of knowing where to find naloxone. The latter is
encouraging as it suggests that people may learn about
naloxone after an overdose in their personal social networks. However, a clear need for educational work in all
areas of the state remains, as no single geographic measure we tested is associated with different levels of naloxone
knowledge. This education could be facilitated by syringe
service programs (SSPs): opportune settings through
which to provide evidence-based, culturally relevant overdose education and naloxone distribution in addition to
sterile syringes and other injection equipment [15]. SSPs,
however, are not authorized in the state of Nebraska [16].
Additionally, over half of respondents reported that
people in their community view individuals who use
drugs as blameworthy, untrustworthy, and dangerous. This finding corroborates and extends research on
stigmatizing beliefs about PWUD in rural areas [7, 8].
Ezell et al. [8] argue that stigma against PWUD may be
intensified by residents’ limited interactions with these
individuals and restricted information diffusion in rural
communities (e.g., news deserts). They emphasize the
need to improve public knowledge of the complex factors
that contribute to opioid use as well as the moral and fiscal value of harm reduction in these areas.
Our findings highlight stigmatizing beliefs about
PWUD and SUD, but also point to promising opportunities for public education. While almost a quarter of
respondents expressed the belief that having a SUD is a
choice, almost 20% were neutral and over half (56%) disagreed or strongly disagreed. Moreover, most respondents
(58%) were neutral regarding the belief that naloxone
access may cause increased drug use. These findings suggest that there may be some receptivity at this critical
moment to educate the public about the experiences of
PWUD, the complexities of SUD, and naloxone as a valuable tool for improving community health.
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Efforts to destigmatize PWUD and SUD should be
coupled with basic education on naloxone. Our findings indicate that most respondents are unable to identify when a person is overdosing, many are unaware of
naloxone, and, of those who are aware of it, few know
how to obtain or use THN. Specifically, our findings
highlight the need for tailored education and outreach
aimed at increasing naloxone knowledge among older
individuals and men. Future efforts to promote THN
in Nebraska could also benefit from the strategies that
Childs and colleagues [7] suggest to promote harm
reduction in non-urban communities: (1) identify local
champions of harm reduction, (2) educate communities about harm reduction strategies before their implementation, (3) make harm reduction visible within
these communities, and (4) secure “buy-in” from a variety of local stakeholders such as law enforcement and
government officials.
Public awareness efforts should be informed by
research on effective strategies to build public support for
THN, such as combining harm reduction education with
sympathetic portrayals of people who use opioids [17].
Naloxone may also be normalized using metaphors that
frame it as similar to medications used to manage other
chronic conditions (e.g., insulin for type 2 diabetes),
medications used to respond to medical emergencies
(e.g., epinephrine for allergic reactions), or other “just in
case” tools (e.g., life insurance) [6]. These messages may
be particularly effective in social media platforms to neutralize stigmatizing messages that are often circulated in
these virtual social spaces.[8].
Additionally, research suggests that reducing opioidrelated overdose may require a multi-strategy approach
including improving Medication for Opioid Use Disorder
(MOUD) access and retention in addition to naloxone
distribution [18]. Yet, this approach is particularly challenging in states like Nebraska, where access to MOUD
is limited and these medications often carry stigma [9].
Increasing access to and acceptability of MOUD, in addition to expanding naloxone awareness and distribution,
will be essential to reducing opioid-related overdose in
these communities.

Limitations
While our findings provide valuable insight on public
knowledge and beliefs about drug use and naloxone in
Nebraska, the limitations of our mail survey methodology should be considered. The response rate of 27.7%
means that survey results may not represent the state
population. The sample was also 90% White and not Hispanic or Latino, higher than U.S. Census estimates of
78% for the state [19]. Finally, survey data are limited in
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its ability to capture nuances in knowledge and beliefs.
Future qualitative research has potential to add depth
and nuance to our findings.

Received: 27 August 2021 Accepted: 21 February 2022

Conclusion
THN is now widely available in much of the U.S. The
benefits of this strategy, however, may be limited by
lack of knowledge and continued stigma of drug use.
Our findings highlight these challenges, but also point
to opportunities to address them through public education. Nebraska, like other largely rural U.S. states, has
experienced a rise of opioid-related overdose during the
COVID-19 pandemic. There is no better time to promote
THN than now, as the public health impact of the pandemic has exacerbated the ongoing overdose crisis.
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